Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bullfrog AI Holdings, Inc.

1.72
+0.13008.18%
Post-market: 1.800.0791+4.60%19:58 EDT
Volume:138.20K
Turnover:234.43K
Market Cap:14.99M
PE:-2.01
High:1.79
Open:1.63
Low:1.60
Close:1.59
Loading ...

Company Profile

Company Name:
Bullfrog AI Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
- -
Office Location:
325 Ellington Boulevard,Unit 317,Gaithersburg,Maryland,United States
Zip Code:
20878
Fax:
- -
Introduction:
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Directors

Name
Position
Vin Singh
Chairman,Chief Executive Officer and Director
Don Elsey
Director
Jason Hanson
Director
William Enright
Director

Shareholders

Name
Position
Vin Singh
Chairman,Chief Executive Officer and Director
Dane Saglio
Chief Financial Officer